microRNA therapeutics

Regulus Therapeutics Inc. is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. MicroRNA...

Regulus Therapeutics executives talking on microRNA

Tour of Regulus Therapeutics' facilities

Neil W. Gibson, Ph.D., Chief Scientific Officer at Regulus Therapeutics, talking on microRNAs as a new class of drug targets

Mary Glanville, Senior Vice President of Human Capital at Regulus Therapeutics, talking on culture and core values

Garry E. Menzel, Ph.D., Chief Operating Officer and Executive Vice President of Finance at Regulus Therapeutics, talking on business strategy and f...

Kleanthis G. Xanthopoulos, Ph.D., President and Chief Executive Officer of Regulus Therapeutics, talking on the impact of microRNA medicines

The discovery of microRNA in humans during the last decade is one of the most exciting scientific breakthroughs in recent history. microRNAs are sm...